海王英特龙2018年报

海王英特龙秉持「健康成就未来」的理念，以现代生物技术与药物制剂技术为创新平台，发展细胞因子类蛋白质治

海王英特龙秉持「健康成就未来」的理念，以现代生物技术与药物制剂技术为创新平台，发展细胞因子类蛋白质治疗药物和预防用生物制品，创建以自主知识产权产品研发和专业化营销能力为代表的核心竞争力，逐步确立国内市

（於中華人民共和國註冊成立之股份有限公司） Stock Code 股份代號 : 8329 * For identification p%5Curpose only 僅供識別之用 年報 A N N %5Cu A L R EP O R T 2012 年 報 Breast Stem cells Creativity

CHARACTERISTICS OF THE GROWTH ENTERPRISE MARKET (“GEM”) OF THE STOCK EXCHANGE OF HONG KONG LIMITED (THE “STOCK EXCHANGE”) GEM has been positioned as a

ANN%5CuAL REPORT 年報 2023 CHARACTERISTICS OF GEM OF THE STOCK EXCHANGE OF HONG KONG LIMITED (THE “STOCK EXCHANGE”) GEM has been positioned as a market des

2021 Ann%5Cual Report 年報 A N N %5Cu A L REPO RT 2021 CHARACTERISTICS OF GEM OF THE STOCK EXCHANGE OF HONG KONG LIMITED (THE “STOCK EXCHANGE”) GEM has been p

（於中華人民共和國註冊成立之股份有限公司） 股份代號 A N N %5Cu A L R EP O R T 2013 年 報 * For identification p%5Curpose only 僅供識別之用 CHARACTERISTICS OF THE GROWTH ENTERPRISE MARKET (“

2020 A N N %5Cu A L REPO RT 2020 CHARACTERISTICS OF GEM OF THE STOCK EXCHANGE OF HONG KONG LIMITED (THE “STOCK EXCHANGE”) GEM has been positioned as a ma

2017 A N N %5Cu A L REPO RT 2017 CHARACTERISTICS OF GEM OF THE STOCK EXCHANGE OF HONG KONG LIMITED (THE “STOCK EXCHANGE”) GEM has been positioned as a ma

2022 ANN%5CuAL REPORT 年報 CHARACTERISTICS OF GEM OF THE STOCK EXCHANGE OF HONG KONG LIMITED (THE “STOCK EXCHANGE”) GEM has been positioned as a market des